Solid Biosciences Ownership 2024 | Who Owns Solid Biosciences Now?
Institutional Ownership
0.00%
Insider Ownership
0.84%
Institutional Holders
1.00
Solid Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | 7 | 1 | 16.67% | 40 | Jun 30, 2024 |
Solid Biosciences's largest institutional shareholder is PARALLEL ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at $40.00. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | 7 | 1 | 16.67% | 40 | Jun 30, 2024 |
The largest Solid Biosciences shareholder by % of total assets is PARALLEL ADVISORS, LLC. The company owns 7.00 shares of Solid Biosciences (SLDB), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | 7 | 1 | 16.67% | 40 | Jun 30, 2024 |
As of Jun 30 2024, Solid Biosciences's largest institutional buyer is PARALLEL ADVISORS, LLC. The company purchased 1.00 stocks of SLDB, valued at $40.00.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC | - | - | 7 | 1 | 16.67% | 40 | Jun 30, 2024 |
As of Jun 30 2024, Solid Biosciences's biggest institutional seller is PARALLEL ADVISORS, LLC. The company sold 1.00 shares of SLDB, valued at $40.00.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Solid Biosciences Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
T. Rowe Price New Horizons Fund, Inc. | 0.39% | 1,968,876 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.12% | 280,500 | - | - | Mar 28, 2024 |
BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 10,839 | - | - | Mar 28, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.03% | 14,964 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.02% | 50,071 | - | - | Mar 28, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.02% | 103,306 | - | - | Mar 31, 2024 |
VANGUARD EXPLORER FUND | 0.02% | 193,436 | - | - | Jan 31, 2024 |
FIRST TRUST EXCHANGE-TRADED FUND | 0.02% | 154,019 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,102 | - | - | Mar 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,399 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.01% | 3,271,172 | - | - | Mar 31, 2024 |
Fidelity Commonwealth Trust II | 0.01% | 50,858 | - | - | Aug 31, 2023 |
BlackRock Advantage SMID Cap Fund, Inc. | 0.00% | 722 | - | - | Mar 28, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 126,405 | - | - | Feb 29, 2024 |
GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 12,542 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 550,979 | - | - | Feb 29, 2024 |
JNL VARIABLE FUND LLC | 0.00% | 14,100 | - | - | Mar 31, 2020 |
Principal Exchange-Traded Funds | 0.00% | 21,879 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 4,720 | - | - | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 44,513 | - | - | Mar 31, 2024 |
Meeder Funds | 0.00% | 6,036 | - | - | Mar 31, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 4,800 | - | - | Mar 31, 2024 |
VANGUARD QUANTITATIVE FUNDS | 0.00% | 4,685 | - | - | Mar 31, 2024 |
HC CAPITAL TRUST | 0.00% | 30,087 | - | - | Mar 31, 2024 |
VANGUARD WORLD FUND | 0.00% | 191,088 | - | - | Feb 29, 2024 |
GPS Funds I | 0.00% | 4,034 | - | - | Mar 31, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 23,367 | - | - | Mar 31, 2024 |
FIDELITY COMMONWEALTH TRUST | 0.00% | 2,205 | - | - | Feb 29, 2024 |
Columbia Funds Variable Series Trust II | 0.00% | 22,054 | - | - | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.00% | 35,500 | - | - | Feb 29, 2024 |
FIDELITY COVINGTON TRUST | 0.00% | 10,098 | - | - | Jan 31, 2024 |
Federated Hermes Global Allocation Fund | 0.00% | 5,339 | - | - | Feb 29, 2024 |
SunAmerica Specialty Series | 0.00% | 204 | - | - | Apr 30, 2021 |
MASTER INVESTMENT PORTFOLIO | 0.00% | 34,854 | - | - | Mar 31, 2024 |
Global X Funds | 0.00% | 16,785 | - | - | Jan 31, 2024 |
MUTUAL FUND SERIES TRUST | 0.00% | 1,081,868 | - | - | Mar 31, 2024 |
RUSSELL INVESTMENT CO | 0.00% | 76,247 | - | - | Jan 31, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 625 | - | - | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 31,633 | - | - | Mar 28, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,700 | - | - | Mar 31, 2024 |
SEASONS SERIES TRUST | 0.00% | 4,300 | - | - | Mar 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,087 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 174,113 | - | - | Mar 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 569 | - | - | Dec 31, 2023 |
FIDELITY SALEM STREET TRUST | 0.00% | 471,527 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 1,275 | - | - | Mar 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 2,452 | - | - | Feb 29, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 4,276 | - | - | Jan 31, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 204,933 | - | - | Feb 29, 2024 |
PGIM ETF TRUST | 0.00% | 6,446 | - | - | Feb 29, 2024 |
SCHWAB STRATEGIC TRUST | 0.00% | 54,609 | - | - | Feb 29, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 314 | - | - | Dec 31, 2023 |
VALIC Co I | 0.00% | 22,101 | - | - | Feb 29, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 73,727 | - | - | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 29,590 | 2,377 | 8.73% | Jan 31, 2024 |
AMERICAN CENTURY ETF TRUST | 0.00% | 7,189 | 7,189 | - | Feb 29, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 355 | - | - | Feb 29, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 7,784 | - | - | Mar 31, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 3,473 | - | - | Feb 29, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 6,553 | - | - | Jan 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 57 | - | - | Dec 31, 2023 |
Blackstone Alternative Investment Funds | 0.00% | 2,900 | - | - | Mar 31, 2023 |
TIAA-CREF FUNDS | 0.00% | 131,407 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 700,136 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 9,749 | - | - | Jan 31, 2024 |
PROSHARES TRUST | 0.00% | 9,885 | - | - | Feb 29, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,460 | - | - | Feb 29, 2024 |
GOLDMAN SACHS TRUST | 0.00% | 85,307 | - | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 49,700 | - | - | Mar 31, 2024 |
ETF Series Solutions | 0.00% | 384 | - | - | Jan 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 140,000 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 17,686 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 16,077 | 5,900 | 57.97% | Jan 31, 2024 |
PENN SERIES FUNDS INC | 0.00% | 400 | - | - | Mar 28, 2024 |
VANGUARD WELLINGTON FUND | 0.00% | 5,000 | - | - | Feb 29, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 4,000 | - | - | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 32,702 | - | - | Mar 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 2,388 | - | - | Jan 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,713 | - | - | Jan 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 5,218 | - | - | Dec 31, 2023 |
Bridge Builder Trust | 0.00% | 22,369 | - | - | Mar 31, 2024 |
John Hancock Funds II | 0.00% | 50,944 | - | - | Feb 29, 2024 |
iShares U.S. ETF Trust | 0.00% | 353 | - | - | Jan 31, 2024 |
NORTHERN FUNDS | 0.00% | 372 | - | - | Mar 28, 2024 |
PROSHARES TRUST | 0.00% | 634 | - | - | Feb 29, 2024 |
BLACKROCK FUNDS | 0.00% | 13,292 | - | - | Mar 28, 2024 |
WisdomTree Trust | 0.00% | 2,845 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,770 | - | - | Mar 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 5,787 | - | - | Mar 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 9,333 | - | - | Jan 31, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 120 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 378 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 3,610 | - | - | Feb 29, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 142 | - | - | Jan 31, 2024 |
AQR Funds | 0.00% | 106,954 | - | - | Mar 31, 2024 |
Solid Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.97M shares, compromising 0.39% of its total assets.
Solid Biosciences Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 1 | - |
31 Mar, 24 | 1 | - |
31 Dec, 23 | 1 | - |
30 Sep, 23 | 1 | -50.00% |
30 Jun, 23 | 2 | - |
31 Mar, 23 | 2 | - |
31 Dec, 22 | 2 | -96.43% |
30 Sep, 22 | 56 | -12.50% |
30 Jun, 22 | 64 | -16.88% |
31 Mar, 22 | 77 | -6.10% |
31 Dec, 21 | 82 | -11.83% |
30 Sep, 21 | 93 | -5.10% |
30 Jun, 21 | 98 | -17.65% |
31 Mar, 21 | 119 | 36.78% |
31 Dec, 20 | 87 | 42.62% |
30 Sep, 20 | 61 | -11.59% |
30 Jun, 20 | 69 | -9.21% |
31 Mar, 20 | 76 | -5.00% |
31 Dec, 19 | 80 | 3.90% |
30 Sep, 19 | 77 | -4.94% |
30 Jun, 19 | 81 | - |
31 Mar, 19 | 81 | 3.85% |
31 Dec, 18 | 78 | 2.63% |
30 Sep, 18 | 76 | 18.75% |
30 Jun, 18 | 64 | 14.29% |
31 Mar, 18 | 56 | - |
As of 30 Jun 24, 1 institutions are holding Solid Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 7 | 16.67% |
31 Mar, 24 | 6 | - |
31 Dec, 23 | 6 | - |
30 Sep, 23 | 6 | -91.67% |
30 Jun, 23 | 72 | - |
31 Mar, 23 | 72 | -99.33% |
31 Dec, 22 | 10,806 | -99.98% |
30 Sep, 22 | 63,576,082 | -1.01% |
30 Jun, 22 | 64,227,589 | -7.32% |
31 Mar, 22 | 69,298,638 | -8.29% |
31 Dec, 21 | 75,561,529 | -1.79% |
30 Sep, 21 | 76,935,179 | -4.04% |
30 Jun, 21 | 80,171,447 | 1.34% |
31 Mar, 21 | 79,109,607 | 44.92% |
31 Dec, 20 | 54,587,572 | 111.39% |
30 Sep, 20 | 25,823,561 | -3.58% |
30 Jun, 20 | 26,782,737 | 36.38% |
31 Mar, 20 | 19,638,958 | -1.25% |
31 Dec, 19 | 19,887,558 | -38.08% |
30 Sep, 19 | 32,117,697 | 51.02% |
30 Jun, 19 | 21,267,222 | 24.27% |
31 Mar, 19 | 17,113,387 | -29.26% |
31 Dec, 18 | 24,190,796 | 30.02% |
30 Sep, 18 | 18,605,083 | 7.35% |
30 Jun, 18 | 17,331,399 | 8.76% |
31 Mar, 18 | 15,935,456 | - |
Solid Biosciences (SLDB) has 7.00 shares outstanding as of 30 Jun 24, up 16.67% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | - | - |
31 Mar, 24 | - | - |
31 Dec, 23 | - | - |
30 Sep, 23 | - | 20725.00% |
30 Jun, 23 | 0.00% | 250000.00% |
31 Mar, 23 | 0.00% | 12.14% |
31 Dec, 22 | 0.06% | 0.01% |
30 Sep, 22 | 21.66% | 4.52% |
30 Jun, 22 | 21.88% | 3.93% |
31 Mar, 22 | 23.61% | 3.56% |
31 Dec, 21 | 25.74% | 3.75% |
30 Sep, 21 | 26.21% | 3.51% |
30 Jun, 21 | 27.31% | 3.76% |
31 Mar, 21 | 26.95% | 7.79% |
31 Dec, 20 | 18.60% | 24.03% |
30 Sep, 20 | 8.80% | 10.57% |
30 Jun, 20 | 9.12% | 20.38% |
31 Mar, 20 | 6.69% | 14.57% |
31 Dec, 19 | 6.78% | 5.66% |
30 Sep, 19 | 10.94% | 20.84% |
30 Jun, 19 | 7.25% | 21.31% |
31 Mar, 19 | 5.83% | 8.58% |
31 Dec, 18 | 8.24% | 20.51% |
30 Sep, 18 | 6.34% | 18.18% |
30 Jun, 18 | 5.90% | 20.03% |
31 Mar, 18 | 5.43% | - |
As of 30 Jun 24, Solid Biosciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | - |
31 Mar, 24 | - | - |
31 Dec, 23 | - | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 1 | -50.00% |
31 Dec, 22 | 2 | -90.48% |
30 Sep, 22 | 21 | -19.23% |
30 Jun, 22 | 26 | 8.33% |
31 Mar, 22 | 24 | -41.46% |
31 Dec, 21 | 41 | 20.59% |
30 Sep, 21 | 34 | -33.33% |
30 Jun, 21 | 51 | -31.08% |
31 Mar, 21 | 74 | 25.42% |
31 Dec, 20 | 59 | 156.52% |
30 Sep, 20 | 23 | -30.30% |
30 Jun, 20 | 33 | -8.33% |
31 Mar, 20 | 36 | -21.74% |
31 Dec, 19 | 46 | - |
30 Sep, 19 | 46 | - |
30 Jun, 19 | 46 | -4.17% |
31 Mar, 19 | 48 | -2.04% |
31 Dec, 18 | 49 | -5.77% |
30 Sep, 18 | 52 | 23.81% |
30 Jun, 18 | 42 | -25.00% |
31 Mar, 18 | 56 | - |
1 institutional shareholders have increased their position in SLDB stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | - |
31 Mar, 24 | - | - |
31 Dec, 23 | - | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | - |
31 Mar, 23 | - | - |
31 Dec, 22 | - | -100.00% |
30 Sep, 22 | 17 | -22.73% |
30 Jun, 22 | 22 | -35.29% |
31 Mar, 22 | 34 | 70.00% |
31 Dec, 21 | 20 | -37.50% |
30 Sep, 21 | 32 | 52.38% |
30 Jun, 21 | 21 | - |
31 Mar, 21 | 21 | 90.91% |
31 Dec, 20 | 11 | -56.00% |
30 Sep, 20 | 25 | 19.05% |
30 Jun, 20 | 21 | -4.55% |
31 Mar, 20 | 22 | 57.14% |
31 Dec, 19 | 14 | 16.67% |
30 Sep, 19 | 12 | -7.69% |
30 Jun, 19 | 13 | -13.33% |
31 Mar, 19 | 15 | -6.25% |
31 Dec, 18 | 16 | 33.33% |
30 Sep, 18 | 12 | -7.69% |
30 Jun, 18 | 13 | - |
31 Mar, 18 | - | - |
- institutional shareholders have reduced their position in SLDB stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 1 | - | 7 | 16.67% | - | - | 1 | - | - | - |
31 Mar, 24 | 1 | - | 6 | - | - | - | - | - | - | - |
31 Dec, 23 | 1 | - | 6 | - | - | - | - | - | - | - |
30 Sep, 23 | 1 | -50.00% | 6 | -91.67% | - | 20725.00% | - | - | - | - |
30 Jun, 23 | 2 | - | 72 | - | 0.00% | 250000.00% | - | -100.00% | - | - |
31 Mar, 23 | 2 | - | 72 | -99.33% | 0.00% | 12.14% | 1 | -50.00% | - | - |
31 Dec, 22 | 2 | -96.43% | 10,806 | -99.98% | 0.06% | 0.01% | 2 | -90.48% | - | -100.00% |
30 Sep, 22 | 56 | -12.50% | 63,576,082 | -1.01% | 21.66% | 4.52% | 21 | -19.23% | 17 | -22.73% |
30 Jun, 22 | 64 | -16.88% | 64,227,589 | -7.32% | 21.88% | 3.93% | 26 | 8.33% | 22 | -35.29% |
31 Mar, 22 | 77 | -6.10% | 69,298,638 | -8.29% | 23.61% | 3.56% | 24 | -41.46% | 34 | 70.00% |
31 Dec, 21 | 82 | -11.83% | 75,561,529 | -1.79% | 25.74% | 3.75% | 41 | 20.59% | 20 | -37.50% |
30 Sep, 21 | 93 | -5.10% | 76,935,179 | -4.04% | 26.21% | 3.51% | 34 | -33.33% | 32 | 52.38% |
30 Jun, 21 | 98 | -17.65% | 80,171,447 | 1.34% | 27.31% | 3.76% | 51 | -31.08% | 21 | - |
31 Mar, 21 | 119 | 36.78% | 79,109,607 | 44.92% | 26.95% | 7.79% | 74 | 25.42% | 21 | 90.91% |
31 Dec, 20 | 87 | 42.62% | 54,587,572 | 111.39% | 18.60% | 24.03% | 59 | 156.52% | 11 | -56.00% |
30 Sep, 20 | 61 | -11.59% | 25,823,561 | -3.58% | 8.80% | 10.57% | 23 | -30.30% | 25 | 19.05% |
30 Jun, 20 | 69 | -9.21% | 26,782,737 | 36.38% | 9.12% | 20.38% | 33 | -8.33% | 21 | -4.55% |
31 Mar, 20 | 76 | -5.00% | 19,638,958 | -1.25% | 6.69% | 14.57% | 36 | -21.74% | 22 | 57.14% |
31 Dec, 19 | 80 | 3.90% | 19,887,558 | -38.08% | 6.78% | 5.66% | 46 | - | 14 | 16.67% |
30 Sep, 19 | 77 | -4.94% | 32,117,697 | 51.02% | 10.94% | 20.84% | 46 | - | 12 | -7.69% |
30 Jun, 19 | 81 | - | 21,267,222 | 24.27% | 7.25% | 21.31% | 46 | -4.17% | 13 | -13.33% |
31 Mar, 19 | 81 | 3.85% | 17,113,387 | -29.26% | 5.83% | 8.58% | 48 | -2.04% | 15 | -6.25% |
31 Dec, 18 | 78 | 2.63% | 24,190,796 | 30.02% | 8.24% | 20.51% | 49 | -5.77% | 16 | 33.33% |
30 Sep, 18 | 76 | 18.75% | 18,605,083 | 7.35% | 6.34% | 18.18% | 52 | 23.81% | 12 | -7.69% |
30 Jun, 18 | 64 | 14.29% | 17,331,399 | 8.76% | 5.90% | 20.03% | 42 | -25.00% | 13 | - |
31 Mar, 18 | 56 | - | 15,935,456 | - | 5.43% | - | 56 | - | - | - |
Solid Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Solid Biosciences's stock was made by SMITH IAN F on Jul 05 2024, selling 3,255 shares at - per share (valued at -). The last insider buy of SLDB was made by Kahn Clare on Jun 11 2024, buying 1,100 shares at $7.67 per share (worth $8.44K).
Solid Biosciences Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 1 | 1 | 100.00% |
Q2 2024 | 10 | 3 | 333.33% |
Q1 2024 | 26 | 8 | 325.00% |
Q4 2023 | 9 | 12 | 75.00% |
Q3 2023 | 2 | 2 | 100.00% |
Q2 2023 | 14 | 4 | 350.00% |
Q1 2023 | 13 | 8 | 162.50% |
Q4 2022 | 35 | 1 | 3500.00% |
Q3 2022 | 1 | 1 | 100.00% |
Q2 2022 | 20 | 1 | 2000.00% |
Q1 2022 | 14 | 4 | 350.00% |
Q2 2021 | 10 | - | - |
Q1 2021 | 16 | 13 | 123.08% |
Q4 2020 | 6 | 1 | 600.00% |
Q3 2020 | 7 | 12 | 58.33% |
Q2 2020 | 18 | 1 | 1800.00% |
Q1 2020 | 18 | 2 | 900.00% |
Q3 2019 | 9 | - | - |
Q2 2019 | 10 | 2 | 500.00% |
Q1 2019 | 9 | 11 | 81.82% |
1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Solid Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q2 2024 | 1 | 1 | 100.00% |
Q1 2024 | 2 | 3 | 66.67% |
Q4 2023 | - | 5 | - |
Q3 2023 | - | - | - |
Q2 2023 | - | 1 | - |
Q1 2023 | - | 3 | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | 4 | - |
Q2 2021 | - | - | - |
Q1 2021 | 2 | 9 | 22.22% |
Q4 2020 | - | - | - |
Q3 2020 | - | 6 | - |
Q2 2020 | - | - | - |
Q1 2020 | - | - | - |
Q3 2019 | 1 | - | - |
Q2 2019 | - | 1 | - |
Q1 2019 | - | 8 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Solid Biosciences's stocks.
Solid Biosciences Peer Ownership
Ticker | Company |
---|---|
PMVP | PMV Pharmaceuticals, Inc. |
CGEM | Cullinan Oncology, Inc. |
RVMD | Revolution Medicines, Inc. Warrant |
LRMR | Larimar Therapeutics, Inc. |
MLYS | Mineralys Therapeutics, Inc. |
EWTX | Edgewise Therapeutics, Inc. |
STOK | Stoke Therapeutics, Inc. |
IPSC | Century Therapeutics, Inc. |
ALEC | Alector, Inc. |
ACRV | Acrivon Therapeutics, Inc. Common Stock |
BDTX | Black Diamond Therapeutics, Inc. |
BCEL | Atreca, Inc. |
CABA | Cabaletta Bio, Inc. |
PASG | Passage Bio, Inc. |
CCCC | C4 Therapeutics, Inc. |
GLUE | Monte Rosa Therapeutics, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
MOLN | Molecular Partners AG |
SLDB Ownership FAQ
Who Owns Solid Biosciences?
Solid Biosciences is owned by institutional shareholders (0%), insiders (0.84%), and public (0%). The largest institutional shareholder of Solid Biosciences is PARALLEL ADVISORS, LLC (0% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.39% of total shares).
Who are the major institutional shareholders of Solid Biosciences?
Solid Biosciences's major institutional shareholders are PARALLEL ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Solid Biosciences shareholders are there?
As of Jun 2024, there are 1 institutional shareholders of Solid Biosciences.
What percentage of Solid Biosciences is owned by PARALLEL ADVISORS, LLC?
PARALLEL ADVISORS, LLC owns 7 shares of Solid Biosciences, representing 0% of the company's total shares outstanding, valued at $40 (as of Jun 2024).